Percutaneous Arteriovenous Fistula Creation with the WavelinQ 4-French EndoAVF System: A Single-Center Retrospective Analysis of 30 Patients

Kitrou, Panagiotis; Balta, Lamprini; Papachristou, Evangelos; Papasotiriou, Marios; Κατσάνος, Κωνσταντίνος; Theofanis, Michail; Papadoulas, Spyridon; Anagnostopoulos, Fotios; Georgopoulou, Georgia; Goumenos, Dimitrios; Karnabatidis, Dimitrios

doi:10.1016/j.jvir.2021.09.021

Cited by 14 publications

(10 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The maturation rates of endovascularly created AVF were 87.00% (95% CI, 0.79–0.93; I 2 = 83.96%; Figure 4 ) ( 8 – 15 , 17 , 18 , 20 ). No statistically significant difference in maturation was observed between the 2 groups (OR = 0.73; 95% CI, 0.20–2.63; P = 0.63; I 2 = 88%; Figure 3B ) ( 23 – 25 ).…”

Section: Resultsmentioning

confidence: 99%

“…There was no statistically significant difference between the endovascular and surgical AVF for the 12-month primary patency (OR = 0.55; 95% CI, 0.22–1.40; P = 0.21; I 2 = 79.00%; Supplementary Figure 5C ) ( 22 – 24 ). The 12-month secondary patency rates of endoAVF were 87% (95% CI, 0.78–0.94; I 2 = 86.69%; Supplementary Figure 8 ) ( 9 – 11 , 16 – 18 , 20 ), and there was no statistically significant difference between the 2 groups (OR = 1.44; 95% CI, 0.85–2.44; P = 0.17; I 2 = 0.00%; Supplementary Figure 5D ) ( 22 – 24 ).…”

Section: Resultsmentioning

confidence: 99%

“…The procedure success rate was 98.00% for endoAVF (95% CI, 0.97-0.99; I 2 = 16.25%; Figure 2) (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(19)(20)(21). There was no statistically significant difference between endovascular and surgical creation of AVF in the procedural success (OR = 0.69; 95% CI, 0.04, 11.98; P = 0.80; I 2 = 53%; Figure 3A) (22,24,25).…”

Section: Primary Outcomes Technique Successmentioning

confidence: 99%

“…Procedure-related complications for endoAVF showed 7% (95% CI, 0.04-0.17; I 2 = 78.31%; Supplementary Figure 1) (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(19)(20)(21), and there was no significant difference between the endovascular and surgical AVF (OR = 1.85; 95% CI, 0.37-9.16; P = 0.45; I 2 = 59%; Supplementary Figure 2A) (23)(24)(25)(26).…”

Section: Secondary Outcomes Operation-related Complicationsmentioning

confidence: 99%

“…The devices allowed more clinicians to perform AVF independently due to the simple operation, which potentially reduced the waiting time and allowed patients to avoid surgical procedures. Moreover, endoAVF creation has shown very promising results in several studies, with high rates of technique success, maturation, and few procedurerelated complications (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26). However, a comprehensive and systematic research evidence of endoAVF is still lacking.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Percutaneous endovascular arteriovenous fistula: A systematic review and meta-analysis

Sun

Liu²,

Shen³

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

ObjectiveCurrently, percutaneous endovascular creation of arteriovenous fistula (AVF) shows excellent outcomes. However, few systematic research evidence to support clinical decision making on the benefit of endovascular AVF is available. The purpose of this study was to evaluate the efficacy and safety of endovascular AVF (endoAVF) in patients with renal failure.MethodsWe searched the Medline, Embase, Cochrane Library, and ClinicalTrials.gov databases for studies on endovascular or endovascular versus surgery for the creation of AVF. Two reviewers independently selected studies and extracted data. A systematic review and meta-analysis were performed by Review Manager 5.4 software (Revman, The Cochrane Collaboration, Oxford, United Kingdom) and Stata 15.0 (Stata Corp, College Station, TX, United States).ResultsA total of 14 case series and 5 cohort studies, with 1,929 patients, were included in this study. The technique success was 98.00% for endoAVF (95% CI, 0.97–0.99; I2 = 16.25%). There was no statistically significant difference in 3 cohort studies between endovascular and surgical AVF for procedural success (OR = 0.69; 95% CI, 0.04–11.98; P = 0.80; I2 = 53%). The maturation rates of endoAVF were 87.00% (95% CI, 0.79–0.93; I2 = 83.96%), and no significant difference was observed in 3 cohort studies between the 2 groups (OR = 0.73; 95% CI, 0.20–2.63; P = 0.63; I2 = 88%). Procedure-related complications for endoAVF was 7% (95% CI, 0.04–0.17; I2 = 78.31%), and it did not show significant difference in 4 cohort studies between the 2 groups (OR = 1.85; 95% CI, 0.37–9.16; P = 0.45; I2 = 59%).ConclusionThe endovascular creation of AVF is potentially effective and safe. These important data may provide evidence to support clinicians and patients in making decisions with endovascular AVF. But further research is great necessary due to lack of randomized controlled studies.

show abstract